Table 2 The history of P. vivax infections in subjects enrolled in the antibody longevity study followed for 12 months
Total number | No. of positive responders at acute phase (%) | Ages | Gender | No. of prior infections | No. of recorded re-infections | ||||
|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | Male | Female | 0 | 1 | > 1 | Symptomatic infection | Asymptomatic infection | ||
16 | 16 (100%) | 44.0 ± 9.35 | 12 | 4 | 15 | 1 | 0 | 1 | 0 |